Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

European Research Council grant · Running

PREDICT PREDICT: PRoviding Effective longitudinal models of RAS DIrect inhibition to Combat Tumor resistance

Coordinator
Universita Degli Studi Di Torino, Italy
Runs
1 January 2025 to 30 June 2026
Status
Running
EU funding
€150k
Total cost
—
Partners
2 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101189458

What the project is doing

In the project's own words, from its summary on CORDIS.

Problem:In 2022, more than half a million lung cancer patients worldwide carrying KRAS mutations faced therapy resistance, a trend on the rise. Such cancers resist standard treatments and targeted therapies, leading to an average survival of 1.2 years post-treatment. The heterogeneous genetic background of KRAS-driven cancer adds further complexity, hindering personalized treatment due to resistance unpredictability. Solution:Our Proof Of Concept (PoC) project PREDICT provides a personalized treatment roadmap for KRAS-mutant lung cancer, available through knowledge and genetic tools generated thanks to our ERC CoG grant KARMA, which was aimed at the understanding of the molecular mechanisms regulating the formation of the functional KRAS complex at the cell membrane.

Using genetically-defined KRAS-mutant cell lines, our lab can facilitate direct comparisons of RAS-targeted treatments, including approved and trial drugs. This effort will empower clinicians to recommend effective strategies based on a patient's specific KRAS mutation, accounting for initial and potential acquired mutations and/or mechanisms of resistance. The model will evolve through in vitro testing, analyzing resistance mechanisms, and predicting therapies based on the patient's mutational landscape.

Importantly, our approach eliminates the need for animal models.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di TorinoTorinoItalyCoordinator
Day One Societa a Responsabilita LimitataRoma RmItalyParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI